Takeda To Hunt For New CNS Therapeutics With Heptares' Technology
This article was originally published in The Pink Sheet Daily
Executive Summary
Making G-Protein coupled receptors in the CNS drugable is the aim of a research collaboration between Takeda and U.K. biotech, Heptares Therapeutics.